The Subcutaneous Drug Delivery Devices Market was valued at USD 9243.80 million in 2018 and is projected to reach USD 17290.47 million by 2027. The market is expected to grow at a CAGR of 7.4 percent from 2019 to 2027, reflecting steady adoption across hospitals, homecare settings, and specialty clinics. Increasing focus on biologics, insulin delivery, and monoclonal antibody therapies is...